{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T05:10:26Z","timestamp":1791090626657,"version":"4.1.0"},"reference-count":42,"publisher":"The Endocrine Society","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,2,1]]},"DOI":"10.1210\/me.2009-0315","type":"journal-article","created":{"date-parts":[[2010,1,5]],"date-time":"2010-01-05T20:44:19Z","timestamp":1262724259000},"page":"436-446","source":"Crossref","is-referenced-by-count":84,"title":["Pasireotide and Octreotide Stimulate Distinct Patterns of sst2A Somatostatin Receptor Phosphorylation"],"prefix":"10.1210","volume":"24","author":[{"given":"Florian","family":"Po\u0308ll","sequence":"first","affiliation":[{"name":"Department of Pharmacology and Toxicology (F.P., S.I., A.L., R.S., S.S.), Friedrich-Schiller-University, 07747 Jena, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Lehmann","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology (D.L.), Otto-von-Guericke-University, 39120 Magdeburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susann","family":"Illing","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology (F.P., S.I., A.L., R.S., S.S.), Friedrich-Schiller-University, 07747 Jena, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihaela","family":"Ginj","sequence":"additional","affiliation":[{"name":"Division of Radiological Chemistry (M.G.), University Hospital Basel, 4031 Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Jacobs","sequence":"additional","affiliation":[{"name":"Department of Pharmacology (S.J.), Julius-Maximilians-University, 97078 Wu\u0308rzburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amelie","family":"Lupp","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology (F.P., S.I., A.L., R.S., S.S.), Friedrich-Schiller-University, 07747 Jena, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"Stumm","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology (F.P., S.I., A.L., R.S., S.S.), Friedrich-Schiller-University, 07747 Jena, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Schulz","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology (F.P., S.I., A.L., R.S., S.S.), Friedrich-Schiller-University, 07747 Jena, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"2019041200285393400_R1","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1038\/nrd1255","article-title":"Opportunities in somatostatin research: biological, chemical and therapeutic aspects.","volume":"2","author":"Weckbecker","year":"2003","journal-title":"Nat Rev Drug Discov"},{"key":"2019041200285393400_R2","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1385\/ENDO:28:1:123","article-title":"Treatment of acromegaly: future.","volume":"28","author":"Donangelo","year":"2005","journal-title":"Endocrine"},{"key":"2019041200285393400_R3","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1097\/01.cco.0000167739.56948.a9","article-title":"Neuroendocrine tumors of the gastrointestinal tract: recent advances in molecular genetics, diagnosis, and treatment.","volume":"17","author":"Oberg","year":"2005","journal-title":"Curr Opin Oncol"},{"key":"2019041200285393400_R4","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1200\/JCO.2007.12.7431","article-title":"Indium-111-pentetreotide scintigraphy and somatostatin receptor subtype 2 expression: new prognostic factors for malignant well-differentiated endocrine tumors.","volume":"26","author":"Asnacios","year":"2008","journal-title":"J Clin Oncol"},{"key":"2019041200285393400_R5","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1210\/jc.2007-1986","article-title":"Selective loss of somatostatin receptor 2 in octreotide-resistant growth hormone-secreting adenomas.","volume":"93","author":"Plo\u0308ckinger","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041200285393400_R6","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1159\/000094325","article-title":"New aspects in the diagnosis and treatment of Cushing disease.","volume":"35","author":"Labeur","year":"2006","journal-title":"Front Horm Res"},{"key":"2019041200285393400_R7","author":"Silva"},{"key":"2019041200285393400_R8","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s11102-005-1404-x","article-title":"The role of somatostatin analogs in Cushing\u2019s disease.","volume":"7","author":"Hoek","year":"2004","journal-title":"Pituitary"},{"key":"2019041200285393400_R9","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1530\/eje.0.1460707","article-title":"SOM230: a novel somatostatin peptidomimetic with broad somatotropin release inhibiting factor (SRIF) receptor binding and a unique antisecretory profile.","volume":"146","author":"Bruns","year":"2002","journal-title":"Eur J Endocrinol"},{"key":"2019041200285393400_R10","doi-asserted-by":"crossref","first-page":"4123","DOI":"10.1210\/en.2002-220219","article-title":"SOM230: a new somatostatin peptidomimetic with potent inhibitory effects on the growth hormone\/insulin-like growth factor-I axis in rats, primates, and dogs.","volume":"143","author":"Weckbecker","year":"2002","journal-title":"Endocrinology"},{"key":"2019041200285393400_R11","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1021\/jm021093t","article-title":"A novel somatostatin mimic with broad somatotropin release inhibitory factor receptor binding and superior therapeutic potential.","volume":"46","author":"Lewis","year":"2003","journal-title":"J Med Chem"},{"key":"2019041200285393400_R12","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.clpt.2005.04.003","article-title":"Pharmacokinetic-pharmacodynamic comparison of a novel multiligand somatostatin analog, SOM230, with octreotide in patients with acromegaly.","volume":"78","author":"Ma","year":"2005","journal-title":"Clin Pharmacol Ther"},{"key":"2019041200285393400_R13","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1530\/eje.1.01876","article-title":"The multi-ligand somatostatin analogue SOM230 inhibits ACTH secretion by cultured human corticotroph adenomas via somatostatin receptor type 5.","volume":"152","author":"Hofland","year":"2005","journal-title":"Eur J Endocrinol"},{"key":"2019041200285393400_R14","first-page":"36","article-title":"Pre-clinical and clinical experiences with novel somatostatin ligands: advantages, disadvantages and new prospects.","volume":"28","author":"Hofland","year":"2005","journal-title":"J Endocrinol Invest"},{"key":"2019041200285393400_R15","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1210\/jc.2003-031344","article-title":"The novel somatostatin analog SOM230 is a potent inhibitor of hormone release by growth hormone- and prolactin-secreting pituitary adenomas in vitro.","volume":"89","author":"Hofland","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041200285393400_R16","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.1210\/jc.2003-031319","article-title":"The novel somatostatin ligand (SOM230) regulates human and rat anterior pituitary hormone secretion.","volume":"89","author":"Murray","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041200285393400_R17","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ando.2008.02.020","article-title":"Preclinical evidences suggest new treatment options for endocrine disorders: Pasireotide (SOM230) and Everolimus (RAD001).","volume":"69","author":"Schmid","year":"2008","journal-title":"Ann Endocrinol"},{"key":"2019041200285393400_R18","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1159\/000080741","article-title":"Functional activity of the multiligand analog SOM230 at human recombinant somatostatin receptor subtypes supports its usefulness in neuroendocrine tumors.","volume":"1(Suppl 80)","author":"Schmid","year":"2004","journal-title":"Neuroendocrinology"},{"key":"2019041200285393400_R19","first-page":"28","article-title":"Short- and long-term effects of octreotide and SOM230 on GH, IGF-I, ACTH, corticosterone and ghrelin in rats.","volume":"28","author":"Schmid","year":"2005","journal-title":"J Endocrinol Invest"},{"key":"2019041200285393400_R20","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1210\/jc.2003-031052","article-title":"A single-dose comparison of the acute effects between the new somatostatin analog SOM230 and octreotide in acromegalic patients.","volume":"89","author":"Hoek","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041200285393400_R21","author":"Hoek"},{"key":"2019041200285393400_R22","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1210\/jc.2008-1919","article-title":"Differential effects of octreotide and pasireotide on somatostatin receptor internalization and trafficking in vitro.","volume":"94","author":"Lesche","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041200285393400_R23","doi-asserted-by":"crossref","first-page":"19762","DOI":"10.1074\/jbc.M110373200","article-title":"Heterodimerization of somatostatin and opioid receptors cross-modulates phosphorylation, internalization, and desensitization.","volume":"277","author":"Pfeiffer","year":"2002","journal-title":"J Biol Chem"},{"key":"2019041200285393400_R24","doi-asserted-by":"crossref","first-page":"21374","DOI":"10.1074\/jbc.M313522200","article-title":"Differential \u03b2-arrestin trafficking and endosomal sorting of somatostatin receptor subtypes.","volume":"279","author":"Tulipano","year":"2004","journal-title":"J Biol Chem"},{"key":"2019041200285393400_R25","doi-asserted-by":"crossref","first-page":"5591","DOI":"10.1074\/jbc.275.8.5591","article-title":"Protein kinase C activation stimulates the phosphorylation and internalization of the sst2A somatostatin receptor.","volume":"275","author":"Hipkin","year":"2000","journal-title":"J Biol Chem"},{"key":"2019041200285393400_R26","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1124\/mol.108.054262","article-title":"Site specificity of agonist and second messenger-activated kinases for sst2A somatostatin receptor phosphorylation.","volume":"76","author":"Liu","year":"2009","journal-title":"Mol Pharmacol"},{"key":"2019041200285393400_R27","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1210\/jc.2007-2272","article-title":"Low levels of raf kinase inhibitory protein in growth hormone-secreting pituitary adenomas correlate with poor response to octreotide treatment.","volume":"93","author":"Fougner","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041200285393400_R28","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/nature02158","article-title":"Protein kinase C switches the Raf kinase inhibitor from Raf-1 to GRK-2.","volume":"426","author":"Lorenz","year":"2003","journal-title":"Nature"},{"key":"2019041200285393400_R29","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s11154-008-9082-4","article-title":"Somatostatin and dopamine receptors as targets for medical treatment of Cushing\u2019s Syndrome.","volume":"10","author":"Bruin","year":"2009","journal-title":"Rev Endocr Metab Disord"},{"key":"2019041200285393400_R30","doi-asserted-by":"crossref","first-page":"3282","DOI":"10.1038\/sj.emboj.7600334","article-title":"Morphine induces terminal micro-opioid receptor desensitization by sustained phosphorylation of serine-375.","volume":"23","author":"Schulz","year":"2004","journal-title":"EMBO J"},{"key":"2019041200285393400_R31","doi-asserted-by":"crossref","first-page":"7157","DOI":"10.1073\/pnas.95.12.7157","article-title":"Role for G protein-coupled receptor kinase in agonist-specific regulation of \u03bc-opioid receptor responsiveness.","volume":"95","author":"Zhang","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041200285393400_R32","doi-asserted-by":"crossref","first-page":"23214","DOI":"10.1074\/jbc.M402125200","article-title":"Differential desensitization, receptor phosphorylation, \u03b2-arrestin recruitment, and ERK1\/2 activation by the two endogenous ligands for the CC chemokine receptor 7.","volume":"279","author":"Kohout","year":"2004","journal-title":"J Biol Chem"},{"key":"2019041200285393400_R33","doi-asserted-by":"crossref","first-page":"9649","DOI":"10.1073\/pnas.0904361106","article-title":"Selective engagement of G protein coupled receptor kinases (GRKs) encodes distinct functions of biased ligands.","volume":"106","author":"Zidar","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019041200285393400_R34","doi-asserted-by":"crossref","first-page":"19452","DOI":"10.1074\/jbc.M101450200","article-title":"Molecular determinants underlying the formation of stable intracellular G protein-coupled receptor-\u03b2-arrestin complexes after receptor endocytosis*.","volume":"276","author":"Oakley","year":"2001","journal-title":"J Biol Chem"},{"key":"2019041200285393400_R35","doi-asserted-by":"crossref","first-page":"17201","DOI":"10.1074\/jbc.M910348199","article-title":"Differential affinities of visual arrestin, \u03b2 arrestin1, and \u03b2 arrestin2 for G protein-coupled receptors delineate two major classes of receptors.","volume":"275","author":"Oakley","year":"2000","journal-title":"J Biol Chem"},{"key":"2019041200285393400_R36","doi-asserted-by":"crossref","first-page":"35518","DOI":"10.1074\/jbc.M405878200","article-title":"Differential kinetic and spatial patterns of \u03b2-arrestin and G protein-mediated ERK activation by the angiotensin II receptor.","volume":"279","author":"Ahn","year":"2004","journal-title":"J Biol Chem"},{"key":"2019041200285393400_R37","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1126\/science.1109237","article-title":"Transduction of receptor signals by \u03b2-arrestins.","volume":"308","author":"Lefkowitz","year":"2005","journal-title":"Science"},{"key":"2019041200285393400_R38","doi-asserted-by":"crossref","first-page":"4519","DOI":"10.1210\/jc.2008-1063","article-title":"Reassessment of sst2 somatostatin receptor expression in human normal and neoplastic tissues using the novel rabbit monoclonal antibody UMB-1.","volume":"93","author":"Fischer","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041200285393400_R39","doi-asserted-by":"crossref","first-page":"14027","DOI":"10.1074\/jbc.M006084200","article-title":"Homo- and heterodimerization of somatostatin receptor subtypes. Inactivation of sst(3) receptor function by heterodimerization with sst(2A).","volume":"276","author":"Pfeiffer","year":"2001","journal-title":"J Biol Chem"},{"key":"2019041200285393400_R40","doi-asserted-by":"crossref","first-page":"5150","DOI":"10.1210\/jc.2003-030262","article-title":"Somatostatin receptor subtypes in human pheochromocytoma: subcellular expression pattern and functional relevance for octreotide scintigraphy.","volume":"88","author":"Mundschenk","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041200285393400_R41","first-page":"1865","article-title":"Immunohistochemical determination of five somatostatin receptors in meningioma reveals frequent overexpression of somatostatin receptor subtype sst2A.","volume":"6","author":"Schulz","year":"2000","journal-title":"Clin Cancer Res"},{"key":"2019041200285393400_R42","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1073\/pnas.0409534102","article-title":"Different G protein-coupled receptor kinases govern G protein and \u03b2-arrestin-mediated signaling of V2 vasopressin receptor.","volume":"102","author":"Ren","year":"2005","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Molecular Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/mend\/article-pdf\/24\/2\/436\/8944158\/mend0436.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,12]],"date-time":"2019-04-12T15:26:06Z","timestamp":1555082766000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/mend\/article\/24\/2\/436\/2684104"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2,1]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,2,1]]}},"URL":"https:\/\/doi.org\/10.1210\/me.2009-0315","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.2067957.1651055","asserted-by":"object"}]},"ISSN":["0888-8809","1944-9917"],"issn-type":[{"value":"0888-8809","type":"print"},{"value":"1944-9917","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,2,1]]}}}